EMZ Partners, a European investment firm, agreed to invest in FotoFinder, a provider of skin visualization technology for early skin cancer detection and aesthetics. Financial terms were not disclosed. "We have been very impressed by the journey of FotoFinder over the recent years to its current market-leading position, and how this successful development has been driven by the Mayer family and the management team. As pioneer in skin imaging and highly reputed brand that has become the “gold standard” par excellence in technology for early skin cancer detection, FotoFinder is now in a unique position to fully exploit its future growth potential. We are very much looking forward to pooling our expertise and successfully reaching the next level of the company together," Klaus Maurer, EMZ Managing Partner.